| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 0 | 51.659 | 67.493 | 17.386 | 29.303 |
| Total Income - EUR | - | - | - | 0 | 0 | 0 | 51.659 | 67.493 | 17.386 | 29.303 |
| Total Expenses - EUR | - | - | - | 56 | 237 | 62 | 4.888 | 8.411 | 12.306 | 18.518 |
| Gross Profit/Loss - EUR | - | - | - | -56 | -237 | -62 | 46.771 | 59.082 | 5.080 | 10.785 |
| Net Profit/Loss - EUR | - | - | - | -56 | -237 | -62 | 45.221 | 57.456 | 4.901 | 9.923 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Sano Citta S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 24 | 0 | 0 | 0 | 0 | 783 | 519 |
| Current Assets | - | - | - | 0 | 0 | 0 | 68.777 | 64.063 | 6.548 | 31.893 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 57.299 | 56.698 | 4.297 | 25.742 |
| Cash | - | - | - | 0 | 0 | 0 | 11.477 | 7.364 | 2.251 | 6.151 |
| Shareholders Funds | - | - | - | -13 | -250 | -266 | 45.261 | 57.504 | 4.950 | 9.971 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 37 | 250 | 266 | 23.515 | 6.558 | 2.381 | 22.441 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Sano Citta S.r.l.